Romosozumab Efficacy in Postmenopausal Women With No Prior Fracture Who Fulfill Criteria for Very High Fracture Risk

Authors:

Abstract
No abstract available
Funding Information
  • UCB Pharma SA
  • Astellas Pharma
  • Amgen

This publication has 21 references indexed in Scilit: